Skip to main content
Top
Published in: Endocrine 3/2020

Open Access 01-03-2020 | Original Article

Cigarette smoking is associated with higher thyroid hormone and lower TSH levels: the PREVEND study

Authors: Eke G. Gruppen, Jenny Kootstra-Ros, Anneke Muller Kobold, Margery A. Connelly, Daan Touw, Jens H. J. Bos, Eelko Hak, Thera P. Links, Stephan J. L. Bakker, Robin P. F. Dullaart

Published in: Endocrine | Issue 3/2020

Login to get access

Abstract

Purpose

The extent to which smoking is associated with thyroid stimulating hormone (TSH), free thyroxine (FT4), and free triiodothyronine (FT3) when taking account of clinical variables including alcohol consumption is unclear. We aimed to determine associations of TSH, FT4, and FT3 levels with current smoking.

Methods

A cross-sectional study was performed in 5766 euthyroid participants (Prevention of Renal and Vascular End-Stage Disease cohort). Current smoking was determined by self-report, categorized as never, former, and current (≤20 and >20 cigarettes per day). Smoke exposure was determined by urinary cotinine.

Results

Current smoking of ≤20 and >20 cigarettes per day was associated with lower TSH and higher FT3 levels. FT4 levels were higher in subjects smoking <20 cigarettes per day vs. never and former smokers. Current smokers also consumed more alcohol. Multivariable linear regression analyses adjusted for age, sex, anti-TPO autoantibody positivity, alcohol consumption, and other variables demonstrated that lower TSH, higher FT4 and higher FT3 were associated with smoking ≤20 cigarettes per day vs. subjects who never smoked (P < 0.001, P = 0.018, and P < 0.001, respectively) without a further significant incremental effect of smoking >20 cigarettes per day. In agreement, TSH was inversely, whereas FT4 and FT3 levels were positively associated with urinary cotinine (P < 0.001 for each). In contrast, alcohol consumption >30 g per day conferred higher TSH and lower FT3 levels.

Conclusions

Cigarette smoking is associated with modestly higher FT4 and FT3, and lower TSH levels, partly opposing effects of alcohol consumption.
Appendix
Available only for authorised users
Literature
1.
go back to reference J.G. Hollowell, N.W. Staehling, W.D. Flanders, W.H. Hannon, E.W. Gunter, C.A. Spencer, L.E. Braverman, Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab. 87, 489–499 (2002)CrossRef J.G. Hollowell, N.W. Staehling, W.D. Flanders, W.H. Hannon, E.W. Gunter, C.A. Spencer, L.E. Braverman, Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab. 87, 489–499 (2002)CrossRef
2.
go back to reference E.H. Hoogendoorn, A.R. Hermus, F. De VegT, H.A. Ross, A.L. Verbeek, L.A. Kiemeney, D.W. Swinkels, F.C. Sweep, M. den Heijer, Thyroid function and prevalence of anti-thyroperoxidase antibodies in a population with borderline sufficient iodine intake: influences of age and sex. Clin. Chem. 52, 104–111 (2006)CrossRef E.H. Hoogendoorn, A.R. Hermus, F. De VegT, H.A. Ross, A.L. Verbeek, L.A. Kiemeney, D.W. Swinkels, F.C. Sweep, M. den Heijer, Thyroid function and prevalence of anti-thyroperoxidase antibodies in a population with borderline sufficient iodine intake: influences of age and sex. Clin. Chem. 52, 104–111 (2006)CrossRef
3.
go back to reference L.J. van Tienhoven‐Wind, R.P. Dullaart, Low–normal thyroid function and the pathogenesis of common cardio‐metabolic disorders. Eur. J. Clin. Investig. 45, 494–503 (2015)CrossRef L.J. van Tienhoven‐Wind, R.P. Dullaart, Low–normal thyroid function and the pathogenesis of common cardio‐metabolic disorders. Eur. J. Clin. Investig. 45, 494–503 (2015)CrossRef
4.
go back to reference P.N. Taylor, D. Albrecht, A. Scholz, G. Gutierrez-Buey, J.H. Lazarus, C.M. Dayan, O.E. Okosieme, Global epidemiology of hyperthyroidism and hypothyroidism. Nat. Rev. Endocrinol. 14, 301–316 (2018)CrossRef P.N. Taylor, D. Albrecht, A. Scholz, G. Gutierrez-Buey, J.H. Lazarus, C.M. Dayan, O.E. Okosieme, Global epidemiology of hyperthyroidism and hypothyroidism. Nat. Rev. Endocrinol. 14, 301–316 (2018)CrossRef
5.
go back to reference B.O. Åsvold, L.J. Vatten, T. Bjøro, D.C. Bauer, A. Bremner, A.R. Cappola, G. Ceresini, W.P. Den Elzen, L. Ferrucci, O.H. Franco, Thyroid function within the normal range and risk of coronary heart disease: an individual participant data analysis of 14 cohorts. JAMA Intern. Med. 175, 1037–1047 (2015)CrossRef B.O. Åsvold, L.J. Vatten, T. Bjøro, D.C. Bauer, A. Bremner, A.R. Cappola, G. Ceresini, W.P. Den Elzen, L. Ferrucci, O.H. Franco, Thyroid function within the normal range and risk of coronary heart disease: an individual participant data analysis of 14 cohorts. JAMA Intern. Med. 175, 1037–1047 (2015)CrossRef
6.
go back to reference R.P. Dullaart, R. De Vries, C. Roozendaal, A.C.M. Kobold, W.J. Sluiter, Carotid artery intima media thickness is inversely related to serum free thyroxine in euthyroid subjects. Clin. Endocrinol. 67, 668–673 (2007)CrossRef R.P. Dullaart, R. De Vries, C. Roozendaal, A.C.M. Kobold, W.J. Sluiter, Carotid artery intima media thickness is inversely related to serum free thyroxine in euthyroid subjects. Clin. Endocrinol. 67, 668–673 (2007)CrossRef
7.
go back to reference A. Bano, K. Dhana, L. Chaker, M. Kavousi, M.A. Ikram, F.U. Mattace-Raso, R.P. Peeters, O.H. Franco, Association of thyroid function with life expectancy with and without cardiovascular disease: the Rotterdam study. JAMA Intern. Med. 177, 1650–1657 (2017)CrossRef A. Bano, K. Dhana, L. Chaker, M. Kavousi, M.A. Ikram, F.U. Mattace-Raso, R.P. Peeters, O.H. Franco, Association of thyroid function with life expectancy with and without cardiovascular disease: the Rotterdam study. JAMA Intern. Med. 177, 1650–1657 (2017)CrossRef
8.
go back to reference L.J.N. van Tienhoven-Wind, E.G. Gruppen, W.J. Sluiter, S.J.L. Bakker, R.P.F. Dullaart, Life expectancy is unaffected by thyroid function parameters in euthyroid subjects: the PREVEND cohort study. Eur. J. Intern. Med. 46, e36–e39 (2017)CrossRef L.J.N. van Tienhoven-Wind, E.G. Gruppen, W.J. Sluiter, S.J.L. Bakker, R.P.F. Dullaart, Life expectancy is unaffected by thyroid function parameters in euthyroid subjects: the PREVEND cohort study. Eur. J. Intern. Med. 46, e36–e39 (2017)CrossRef
9.
go back to reference J.B. Bertelsen, L. HEGEDÜS, Cigarette smoking and the thyroid. Thyroid 4, 327–331 (1994)CrossRef J.B. Bertelsen, L. HEGEDÜS, Cigarette smoking and the thyroid. Thyroid 4, 327–331 (1994)CrossRef
10.
go back to reference W.M. Wiersinga, Smoking and thyroid. Clin. Endocrinol. 79, 145–151 (2013)CrossRef W.M. Wiersinga, Smoking and thyroid. Clin. Endocrinol. 79, 145–151 (2013)CrossRef
11.
go back to reference A. Melander, E. Nordenskjöld, B. Lundh, J. Thorell, Influence of smoking on thyroid activity. Acta Med. Scand. 209, 41–43 (1981)CrossRef A. Melander, E. Nordenskjöld, B. Lundh, J. Thorell, Influence of smoking on thyroid activity. Acta Med. Scand. 209, 41–43 (1981)CrossRef
12.
go back to reference I. Meral, A. Arslan, A. Him, H. Arslan, Smoking-related alterations in serum levels of thyroid hormones and insulin in female and male students. Altern. Ther. Health Med. 21, 24–29 (2015)PubMed I. Meral, A. Arslan, A. Him, H. Arslan, Smoking-related alterations in serum levels of thyroid hormones and insulin in female and male students. Altern. Ther. Health Med. 21, 24–29 (2015)PubMed
13.
go back to reference R. Jorde, J. Sundsfjord, Serum TSH levels in smokers and non-smokers. The 5th Tromsø study. Exp. Clin. Endocrinol. Diabetes 114, 343–347 (2006)CrossRef R. Jorde, J. Sundsfjord, Serum TSH levels in smokers and non-smokers. The 5th Tromsø study. Exp. Clin. Endocrinol. Diabetes 114, 343–347 (2006)CrossRef
14.
go back to reference O.P. Soldin, B.E. Goughenour, S.Z. Gilbert, H.J. Landy, S.J. Soldin, Thyroid hormone levels associated with active and passive cigarette smoking. Thyroid 19, 817–823 (2009)CrossRef O.P. Soldin, B.E. Goughenour, S.Z. Gilbert, H.J. Landy, S.J. Soldin, Thyroid hormone levels associated with active and passive cigarette smoking. Thyroid 19, 817–823 (2009)CrossRef
15.
go back to reference S. Kim, M.J. Kim, S.G. Yoon, J.P. Myong, H.W. Yu, Y.J. Chai, J.Y. Choi, K.E. Lee, Impact of smoking on thyroid gland: dose-related effect of urinary cotinine levels on thyroid function and thyroid autoimmunity. Sci. Rep. 9, 4213 (2019)CrossRef S. Kim, M.J. Kim, S.G. Yoon, J.P. Myong, H.W. Yu, Y.J. Chai, J.Y. Choi, K.E. Lee, Impact of smoking on thyroid gland: dose-related effect of urinary cotinine levels on thyroid function and thyroid autoimmunity. Sci. Rep. 9, 4213 (2019)CrossRef
16.
go back to reference P. Valeix, P. Faure, S. Bertrais, A. Vergnaud, L. Dauchet, S. Hercberg, Effects of light to moderate alcohol consumption on thyroid volume and thyroid function. Clin. Endocrinol. 68, 988–995 (2008)CrossRef P. Valeix, P. Faure, S. Bertrais, A. Vergnaud, L. Dauchet, S. Hercberg, Effects of light to moderate alcohol consumption on thyroid volume and thyroid function. Clin. Endocrinol. 68, 988–995 (2008)CrossRef
17.
go back to reference S. Ozsoy, E. Esel, H.B. Izgi, S. Sofuoglu, Thyroid function in early and late alcohol withdrawal: relationship with aggression, family history, and onset age of alcoholism. Alcohol Alcohol 41, 515–521 (2006)CrossRef S. Ozsoy, E. Esel, H.B. Izgi, S. Sofuoglu, Thyroid function in early and late alcohol withdrawal: relationship with aggression, family history, and onset age of alcoholism. Alcohol Alcohol 41, 515–521 (2006)CrossRef
18.
go back to reference S.N. Slagter, J.V. van Vliet-Ostaptchouk, J.M. Vonk, H.M. Boezen, R.P. Dullaart, A.C.M. Kobold, E.J. Feskens, A.P. van Beek, K. van der, M. Melanie, B.H: Wolffenbuttel, Combined effects of smoking and alcohol on metabolic syndrome: the LifeLines cohort study. PLoS ONE 9, e96406 (2014)CrossRef S.N. Slagter, J.V. van Vliet-Ostaptchouk, J.M. Vonk, H.M. Boezen, R.P. Dullaart, A.C.M. Kobold, E.J. Feskens, A.P. van Beek, K. van der, M. Melanie, B.H: Wolffenbuttel, Combined effects of smoking and alcohol on metabolic syndrome: the LifeLines cohort study. PLoS ONE 9, e96406 (2014)CrossRef
19.
go back to reference E.G. Gruppen, S.J. Bakker, R.W. James, R.P. Dullaart, Serum paraoxonase-1 activity is associated with light to moderate alcohol consumption: the PREVEND cohort study. Am. J. Clin. Nutr. 108, 1283–1290 (2018)CrossRef E.G. Gruppen, S.J. Bakker, R.W. James, R.P. Dullaart, Serum paraoxonase-1 activity is associated with light to moderate alcohol consumption: the PREVEND cohort study. Am. J. Clin. Nutr. 108, 1283–1290 (2018)CrossRef
20.
go back to reference S.E. Borggreve, H.L. Hillege, B.H. Wolffenbuttel, P.E. de Jong, S.J. Bakker, G. van der Steege, A. van Tol, R.P. DullaartPREVEND Study Group, The effect of cholesteryl ester transfer protein -629C->A promoter polymorphism on high-density lipoprotein cholesterol is dependent on serum triglycerides. J. Clin. Endocrinol. Metab. 90, 4198–4204 (2005).CrossRef S.E. Borggreve, H.L. Hillege, B.H. Wolffenbuttel, P.E. de Jong, S.J. Bakker, G. van der Steege, A. van Tol, R.P. DullaartPREVEND Study Group, The effect of cholesteryl ester transfer protein -629C->A promoter polymorphism on high-density lipoprotein cholesterol is dependent on serum triglycerides. J. Clin. Endocrinol. Metab. 90, 4198–4204 (2005).CrossRef
21.
go back to reference H.J. Lambers Heerspink, A.H. Brantsma, D. de Zeeuw, S.J. Bakker, P.E. de Jong, R.T. Gansevoort, PREVEND Study Group, Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality. Am. J. Epidemiol. 168, 897–905 (2008)CrossRef H.J. Lambers Heerspink, A.H. Brantsma, D. de Zeeuw, S.J. Bakker, P.E. de Jong, R.T. Gansevoort, PREVEND Study Group, Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality. Am. J. Epidemiol. 168, 897–905 (2008)CrossRef
22.
go back to reference S.H. Koning, R.T. Gansevoort, K.J. Mukamal, E.B. Rimm, S.J. Bakker, M.M. Joosten, Alcohol consumption is inversely associated with the risk of developing chronic kidney disease. Kidney Int. 87, 1009–1016 (2015)CrossRef S.H. Koning, R.T. Gansevoort, K.J. Mukamal, E.B. Rimm, S.J. Bakker, M.M. Joosten, Alcohol consumption is inversely associated with the risk of developing chronic kidney disease. Kidney Int. 87, 1009–1016 (2015)CrossRef
23.
go back to reference A. Abbasi, E. Corpeleijn, R.T. Gansevoort, R.O. Gans, H.L. Hillege, R.P. Stolk, G. Navis, S.J. Bakker, R.P. Dullaart, Role of HDL cholesterol and estimates of HDL particle composition in future development of type 2 diabetes in the general population: the PREVEND study. J. Clin. Endocrinol. Metab. 98, E1352–E1359 (2013)CrossRef A. Abbasi, E. Corpeleijn, R.T. Gansevoort, R.O. Gans, H.L. Hillege, R.P. Stolk, G. Navis, S.J. Bakker, R.P. Dullaart, Role of HDL cholesterol and estimates of HDL particle composition in future development of type 2 diabetes in the general population: the PREVEND study. J. Clin. Endocrinol. Metab. 98, E1352–E1359 (2013)CrossRef
24.
go back to reference R. Sediq, J. van der Schans, A. Dotinga, R.A. Alingh, B. Wilffert, J.H. Bos, C.C. Schuiling-Veninga, E. Hak, Concordance assessment of self-reported medication use in the netherlands three-generation lifelines Cohort study with the pharmacy database iaDB. nl: the Pharmlines initiative. Clin. Epidemiol. 10, 981–989 (2018)CrossRef R. Sediq, J. van der Schans, A. Dotinga, R.A. Alingh, B. Wilffert, J.H. Bos, C.C. Schuiling-Veninga, E. Hak, Concordance assessment of self-reported medication use in the netherlands three-generation lifelines Cohort study with the pharmacy database iaDB. nl: the Pharmlines initiative. Clin. Epidemiol. 10, 981–989 (2018)CrossRef
25.
go back to reference L.A. Inker, C.H. Schmid, H. Tighiouart, J.H. Eckfeldt, H.I. Feldman, T. Greene, J.W. Kusek, J. Manzi, F. Van Lente, Y.L. Zhang, Estimating glomerular filtration rate from serum creatinine and cystatin C. N. Engl. J. Med. 367, 20–29 (2012)CrossRef L.A. Inker, C.H. Schmid, H. Tighiouart, J.H. Eckfeldt, H.I. Feldman, T. Greene, J.W. Kusek, J. Manzi, F. Van Lente, Y.L. Zhang, Estimating glomerular filtration rate from serum creatinine and cystatin C. N. Engl. J. Med. 367, 20–29 (2012)CrossRef
26.
go back to reference S.P. Matyus, P.J. Braun, J. Wolak-Dinsmore, E.J. Jeyarajah, I. Shalaurova, Y. Xu, S.M. Warner, T.S. Clement, M.A. Connelly, T.J. Fischer, NMR measurement of LDL particle number using the Vantera® clinical analyzer. Clin. Biochem. 47, 203–210 (2014)CrossRef S.P. Matyus, P.J. Braun, J. Wolak-Dinsmore, E.J. Jeyarajah, I. Shalaurova, Y. Xu, S.M. Warner, T.S. Clement, M.A. Connelly, T.J. Fischer, NMR measurement of LDL particle number using the Vantera® clinical analyzer. Clin. Biochem. 47, 203–210 (2014)CrossRef
27.
go back to reference J. Kang, E. Kong, J. Choi, Associations of urinary cotinine-verified active and passive smoking with thyroid function: analysis of population-based nationally representative data. Thyroid 28, 583–592 (2018)CrossRef J. Kang, E. Kong, J. Choi, Associations of urinary cotinine-verified active and passive smoking with thyroid function: analysis of population-based nationally representative data. Thyroid 28, 583–592 (2018)CrossRef
28.
go back to reference R.M. Belin, B.C. Astor, N.R. Powe, P.W. Ladenson, Smoke exposure is associated with a lower prevalence of serum thyroid autoantibodies and thyrotropin concentration elevation and a higher prevalence of mild thyrotropin concentration suppression in the third National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab. 89, 6077–6086 (2004)CrossRef R.M. Belin, B.C. Astor, N.R. Powe, P.W. Ladenson, Smoke exposure is associated with a lower prevalence of serum thyroid autoantibodies and thyrotropin concentration elevation and a higher prevalence of mild thyrotropin concentration suppression in the third National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab. 89, 6077–6086 (2004)CrossRef
29.
go back to reference P.E. Cryer, M.W. Haymond, J.V. Santiago, S.D. Shah, Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N. Engl. J. Med. 295, 573–577 (1976)CrossRef P.E. Cryer, M.W. Haymond, J.V. Santiago, S.D. Shah, Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N. Engl. J. Med. 295, 573–577 (1976)CrossRef
30.
go back to reference L. Mehran, A. Amouzgar, H. Delshad, F. Azizi, The association of cigarette smoking with serum TSH concentration and thyroperoxidase antibody. Exp. Clin. Endocrinol. Diabetes 120, 80–83 (2012)CrossRef L. Mehran, A. Amouzgar, H. Delshad, F. Azizi, The association of cigarette smoking with serum TSH concentration and thyroperoxidase antibody. Exp. Clin. Endocrinol. Diabetes 120, 80–83 (2012)CrossRef
31.
go back to reference S. Park, W.G. Kim, M.J. Jeon, M. Kim, H. Oh, M. Han, T.Y. Kim, Y.K. Shong, W.B. Kim, Serum thyroid‐stimulating hormone levels and smoking status: data from the Korean National Health and Nutrition Examination Survey VI. Clin. Endocrinol 88, 969–976 (2018)CrossRef S. Park, W.G. Kim, M.J. Jeon, M. Kim, H. Oh, M. Han, T.Y. Kim, Y.K. Shong, W.B. Kim, Serum thyroid‐stimulating hormone levels and smoking status: data from the Korean National Health and Nutrition Examination Survey VI. Clin. Endocrinol 88, 969–976 (2018)CrossRef
32.
go back to reference R.P. Dullaart, K. Hoogenberg, B.D. Dikkeschei, A. van Tol, Higher plasma lipid transfer protein activities and unfavorable lipoprotein changes in cigarette-smoking men. Arterioscler. Thromb. 14, 1581–1585 (1994)CrossRef R.P. Dullaart, K. Hoogenberg, B.D. Dikkeschei, A. van Tol, Higher plasma lipid transfer protein activities and unfavorable lipoprotein changes in cigarette-smoking men. Arterioscler. Thromb. 14, 1581–1585 (1994)CrossRef
33.
go back to reference L. Chaker, C. Baumgartner, W.P. Den Elzen, T. Collet, M.A. Ikram, M.R. Blum, A. Dehghan, C. Drechsler, R.N. Luben, M.L. Portegies, Thyroid function within the reference range and the risk of stroke: an individual participant data analysis. J. Clin. Endocrinol. Metab. 101, 4270–4282 (2016)CrossRef L. Chaker, C. Baumgartner, W.P. Den Elzen, T. Collet, M.A. Ikram, M.R. Blum, A. Dehghan, C. Drechsler, R.N. Luben, M.L. Portegies, Thyroid function within the reference range and the risk of stroke: an individual participant data analysis. J. Clin. Endocrinol. Metab. 101, 4270–4282 (2016)CrossRef
34.
go back to reference V. van de, C. Annenienke, R.T. Netea-Maier, F. de Vegt, H.A. Ross, F.C. Sweep, L.A. Kiemeney, J.W. Smit, A.R. Hermus, M. den Heijer, Associations between thyroid function and mortality: the influence of age. Eur. J. Endocrinol. 171, 183–191 (2014)CrossRef V. van de, C. Annenienke, R.T. Netea-Maier, F. de Vegt, H.A. Ross, F.C. Sweep, L.A. Kiemeney, J.W. Smit, A.R. Hermus, M. den Heijer, Associations between thyroid function and mortality: the influence of age. Eur. J. Endocrinol. 171, 183–191 (2014)CrossRef
35.
go back to reference V. van de, C. Annenienke, R.T. Netea-Maier, J.W. Smit, R. Kusters, S. van der, W.J. Jos, C.J. Pronk-Admiraal, M.M. Buijs, C.H. Schoenmakers, S.G. Koehorst, M.J. de Groot, Thyrotropin versus age relation as an indicator of historical iodine intake. Thyroid 25, 629–634 (2015)CrossRef V. van de, C. Annenienke, R.T. Netea-Maier, J.W. Smit, R. Kusters, S. van der, W.J. Jos, C.J. Pronk-Admiraal, M.M. Buijs, C.H. Schoenmakers, S.G. Koehorst, M.J. de Groot, Thyrotropin versus age relation as an indicator of historical iodine intake. Thyroid 25, 629–634 (2015)CrossRef
36.
go back to reference M. Geurts, J. Verkaik-Kloosterman. De jodiuminname van de Nederlandse bevolking na verdere zoutverlaging in brood. RIVM. (2014) M. Geurts, J. Verkaik-Kloosterman. De jodiuminname van de Nederlandse bevolking na verdere zoutverlaging in brood. RIVM. (2014)
37.
go back to reference H.G. Kang, K.H. Kwon, I.W. Lee, B. Jung, E. Park, S. Jang, Biochemically-verified smoking rate trends and factors associated with inaccurate self-reporting of smoking habits in Korean women. Asian Pac. J. Cancer Prev. 14, 6807–6812 (2013)CrossRef H.G. Kang, K.H. Kwon, I.W. Lee, B. Jung, E. Park, S. Jang, Biochemically-verified smoking rate trends and factors associated with inaccurate self-reporting of smoking habits in Korean women. Asian Pac. J. Cancer Prev. 14, 6807–6812 (2013)CrossRef
38.
go back to reference S.K. Kunutsor, J.M. Spee, L.M. Kieneker, R.T. Gansevoort, R.P. Dullaart, A. Voerman, D.J. Touw, S.J. Bakker, Self‐Reported smoking, urine cotinine, and risk of cardiovascular disease: findings from the PREVEND (Prevention of Renal and Vascular End‐Stage Disease) prospective cohort study. J. Am. Heart Assoc. 7, e008726 (2018)CrossRef S.K. Kunutsor, J.M. Spee, L.M. Kieneker, R.T. Gansevoort, R.P. Dullaart, A. Voerman, D.J. Touw, S.J. Bakker, Self‐Reported smoking, urine cotinine, and risk of cardiovascular disease: findings from the PREVEND (Prevention of Renal and Vascular End‐Stage Disease) prospective cohort study. J. Am. Heart Assoc. 7, e008726 (2018)CrossRef
Metadata
Title
Cigarette smoking is associated with higher thyroid hormone and lower TSH levels: the PREVEND study
Authors
Eke G. Gruppen
Jenny Kootstra-Ros
Anneke Muller Kobold
Margery A. Connelly
Daan Touw
Jens H. J. Bos
Eelko Hak
Thera P. Links
Stephan J. L. Bakker
Robin P. F. Dullaart
Publication date
01-03-2020
Publisher
Springer US
Published in
Endocrine / Issue 3/2020
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-019-02125-2

Other articles of this Issue 3/2020

Endocrine 3/2020 Go to the issue